RAC1 and cancer: Rac1 has been consistently involved in the activation of pro-survival pathways in cancer cells, such as NF-κB, thereby counterbalancing the apoptotic responses triggered by chemotherapeutic agents and radiation therapy (Friedland et al., 2007; Han et al., 2013; Wang et al., 2013, 2016; Hein et al., 2016).